Top Defibrillator Brands Revolutionizing Cardiac Care

The significance of reliable and efficient defibrillators cannot be overstated, especially in life-or-death situations where every second counts. With advancements in medical technology, numerous brands have emerged, offering state-of-the-art defibrillators designed to meet a range of medical needs. From portable models for emergency responders to sophisticated units for hospitals, the market is flooded with options promising quality and effectiveness. To guide you through choosing the best, a comprehensive list of top defibrillator brands is provided below.

Illustration of defibrillators

Best brands of defibrillators in 2025

Philips

Philips is a leading producer of defibrillators, known for its high-quality and reliable devices such as the HeartStart OnSite and HeartStart MRx. By 2021, Boston Scientific and Philips, among other manufacturers, had significantly contributed to the global defibrillator market, with Philips' devices being widely used in hospitals and public access points. For instance, Philips reported that approximately 659,000 ICDs had been distributed worldwide by January 2021, indicating a high demand for their products. The company's focus on advanced technology and user-friendly designs has made their defibrillators a preferred choice, with North America dominating the market with a significant share due to favorable regulations and increasing installations in public places. For more information, you can read the HeartStart OnSite Defibrillator manual.

Zoll Medical

ZOLL Medical Corporation is a leading producer of defibrillators, renowned for its innovative and life-saving medical devices. The company's products, such as the ZOLL AED Plus, offer advanced features like real-time CPR feedback and durable designs, making them highly effective in emergency situations. With a significant presence in the global defibrillator market, ZOLL has contributed to saving thousands of lives over more than two decades, particularly through its LifeVest Wearable Defibrillator, which has protected over one million patients. The North American market, where ZOLL has a strong presence, accounted for 42.93% of the external defibrillators market share in 2023. ZOLL's market penetration and growth rate are notable, with a global market potential exceeding $10 billion and a mid-teens growth rate.

Physio-Control

Physio-Control, now a part of Stryker, is a leading producer of defibrillators, known for its advanced medical devices such as the LIFEPAK 15 monitor/defibrillator, which features six main operating modes and high accuracy in ECG analysis and blood pressure measurement. The company's products are widely used in hospitals and pre-hospital settings, contributing significantly to the global defibrillator market, which was valued at USD 13.69 billion in 2022 and is expected to grow at a CAGR of 8.47% from 2023 to 2032. Physio-Control's devices, such as the LIFEPAK 15, offer biphasic waveform defibrillation with energy levels ranging from 150 to 360 joules, and features like cprMAX(tm) technology to maximize CPR time. The company's products have been instrumental in improving cardiac arrest treatment, with a strong presence in the market dominated by players like Medtronic and Boston Scientific. Physio-Control's innovations have aided in the expansion of the defibrillator market, particularly in regions like North America, which held a 37.88% market share in 2022. For more detailed information, explore the LIFEPAK 15 data sheet.

Cardiac Science

Cardiac Science, though not specifically highlighted in the provided sources, is often recognized as a significant player in the defibrillator market due to its innovative products and wide market presence. The global defibrillator market, which includes brands like Cardiac Science, was valued at USD 13.69 billion in 2022 and is expected to grow at a CAGR of 8.47% from 2023 to 2032, reaching USD 30.88 billion by 2032. The market is driven by the increasing prevalence of cardiovascular diseases and the need for life-saving solutions like defibrillators. Implantable Cardioverter Defibrillators (ICDs), a segment where Cardiac Science operates, held a 59.03% market share in 2022. Advanced technologies and public access to defibrillators are key factors in the market's growth.

Schiller

Schiller, a prominent player in the defibrillator market, is known for its innovative and reliable medical devices. The company, part of Schiller Americas Inc., focuses on new product launches, partnerships, and acquisitions to expand its business, contributing to the fragmented yet competitive external defibrillator market. Schiller's products are part of the broader market that was valued at USD 13.69 billion in 2022 and is expected to grow at a CAGR of 8.47% from 2023 to 2032. The company's emphasis on technological advancements and strategic collaborations helps in meeting the increasing demand for defibrillators, particularly driven by the rising incidence of cardiovascular diseases and the need for public access defibrillators. As a key player, Schiller competes with other major brands like Koninklijke Philips N.V., Nihon Kohden Corporation, and Zoll Medical Corporation. For more information, you can explore their range of defibrillators on their website.

Nihon Kohden

Nihon Kohden is a leading global manufacturer of medical electronic equipment, particularly renowned for its defibrillators. As the sole AED manufacturer in Japan, Nihon Kohden holds a significant market share and has delivered over 360,000 AED units worldwide following its acquisition of Defibtech in 2012. The company's defibrillator sales have seen substantial growth, with a 54.8% increase in AED sales in the first half of FY2023. Nihon Kohden's products are used in over 120 countries and are highly regarded for their quality and innovation, including advanced technologies like full-color interactive video displays in their AEDs. For more details, visit their official news release.

Mindray

Mindray is a leading producer of defibrillators, known for its innovative and reliable products. The company's BeneHeart series defibrillation system sets a new standard for lightweight design and effective on-site diagnosis and rescue treatment. By 2022, Mindray's products covered nearly 110,000 medical institutions and over 99% of class III hospitals in China, solidifying its market position. The company has also made significant strides globally, benefiting from long-term market cultivation and brand building, particularly in North America and Western Europe. Mindray's revenue has seen a year-on-year improvement, achieving the 27th position in global medical device companies in 2022.

Lifepak

The Lifepak brand, owned by Physio-Control, is renowned for producing some of the most comprehensive and reliable defibrillators, widely used by paramedics, nurses, and physicians. The Lifepak 15, for example, features a 12-lead ECG, biphasic technology, and a CPR metronome, making it a versatile tool in acute cardiac care. These devices are portable, easy to transport, and equipped with advanced features such as noninvasive pacing and pulse oximetry. The Lifepak series has seen significant adoption, with Boston Scientific reporting the deployment of thousands of such devices globally by 2020. This trust in the brand is underscored by its FDA approval and the high-quality refurbishment services provided by companies like Soma Technology.

Defibtech

Defibtech is a renowned global leader in the manufacture of Automated External Defibrillators (AEDs), designed to save lives from Sudden Cardiac Arrest (SCA). With over 450,000 AED units sold worldwide, Defibtech's products are recognized for their innovative design, quality, and service. Despite being overshadowed by larger brands, Defibtech's AEDs are state-of-the-art, easy to use for both non-medical and professional responders, and technically reliable. The company has enhanced its digital presence through successful marketing campaigns, including social media and PPC advertising. Defibtech's products have earned numerous awards, solidifying its position as a key player in the defibrillator market. For more detailed information, visit their Defibrillator FAQ page.

Heartsine

Heartsine is a leading producer of defibrillators, renowned for its innovative and clinically validated technology. Their devices, such as the samaritan PAD, offer integrated real-time CPR feedback, are highly portable, and have a low cost of ownership. Heartsine's products are designed for ease of use, with voice and visual prompts to guide users through the CPR process, making them accessible even for those without extensive medical training. The company's devices are indicated for use on patients over 8 years old or 55 lbs, and they also provide pediatric pads for younger patients. Heartsine's commitment to innovation and user-friendly design has made their defibrillators a crucial tool in saving lives during cardiac emergencies.